Envoy Medical Operating Income 2021-2024 | COCH
Envoy Medical operating income from 2021 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Envoy Medical Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-19 |
| 2023 | $-18 |
| 2022 | $-9 |
| 2021 | $-5 |
| 2020 | $0 |
| Envoy Medical Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-5 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $-5 |
| 2024-03-31 | $-5 |
| 2023-12-31 | $-7 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $-5 |
| 2022-09-30 | $-2 |
| 2022-06-30 | $-1 |
| 2022-03-31 | $-1 |
| 2021-12-31 | $0 |
| 2021-09-30 | $-3 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $-1 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.029B | $0.000B |
| Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota. | |||